Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2019 PRIZE WINNERS

2019 Prize Winners

News

May 21, 2019
PRESS RELEASE: PERSHING SQUARE SOHN PRIZE AWARDS $4.2M TO SEVEN “NEXT GENERATION” INNOVATORS IN CANCER RESEARCH

Business Wire — The Pershing Square Sohn Cancer Research Alliance today announced the seven winners of the 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to talented New York City-area cancer research scientists and physician-scientists.  The Prize, totaling $4.2 million in funding awarded, emboldens early-career investigators to pursue research projects at a stage when traditional funding is lacking. Recipients receive $200,000 per year for up to three years.  The awards will be presented on May 22, 2019.

READ MORE

Events

October 23, 2018 
SECOND ANNUAL PERSHING SQUARE SOHN RETREAT

On Tuesday, October 23rd, 2018, the Pershing Square Sohn Cancer Research Alliance held its Second Annual Pershing Square Sohn Retreat in Nicholls-Biondi Hall at Cold Spring Harbor Laboratory in Long Island. The Retreat gave the 2015 Pershing Square Sohn Prize winners, who had just finished their final year of funding, the chance to present their work performed over the past three years to their peers and mentors.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation